Answers are grounded in this paper and cite their sources.
VAC and VAI or VIE with surgery (with or without RT), are equally effective for patients with local or regional rhabdomyosarcoma and are more effective for embryonal tumors than therapies used previously. Younger patients with group 1 paratesticular embryonal tumors and all patients with group 1/2 orbit or eyelid tumors can usually be cured with VA chemotherapy along with postoperative RT for group 2 disease.
No takes yet. Share an insight, caveat, or question.
Crist et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: